Published price vs quote-only
Shed vs SnagRx: Which One Publishes Its Price? (2026)
Shed or SnagRx? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.9 and 7.5 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Put Shed and SnagRx side by side and the marketing reads almost identically. The programs underneath do not.
SnagRx publishes what it charges — Semaglutide $99/mo month-to-month, or $69/mo on the 12-month plan. Shed does not: Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. That asymmetry is the comparison, because you can only price-check one of these two before handing over a medical history.
The comparison below starts from published pricing, converts it into annual cost, and then asks what the more expensive side is delivering for the difference. No number here is inferred; if a provider does not publish it, the table says so.
The short answer
- Easier to price in advance
- SnagRx — Semaglutide $99/mo month-to-month, or $69/mo on the 12-month plan. The other side quotes after intake, so a like-for-like total is not available before you apply.
- FDA-approved medication
- Shed — The only side that can write an approved brand-name product at all — it offers name-brand FDA-approved GLP-1 and compounded GLP-1.
- Tirzepatide access
- SnagRx — Tirzepatide at $149/mo; the other side publishes semaglutide only.
- Easiest to pay for
- Shed — Neither publishes financing; both expect the full amount monthly.
The short version: Shed vs SnagRx
The rows below are the ones that differ enough between these two to be worth your attention.
| Shed | SnagRx | |
|---|---|---|
| Advertised price | 10% off the first month, price quoted after intake | Semaglutide $99/mo month-to-month, or $69/mo on the 12-month plan |
| Rate after promotions | not published before intake | $99/mo |
| Pricing structure | Quoted only after intake | Flat rate at every dose |
| Medication | Name-brand FDA-approved GLP-1 and compounded GLP-1 | Compounded semaglutide and compounded tirzepatide |
| Price transparency | Quote only, after intake | Published upfront |
| Membership fee | Not stated | None |
| How fast you start | 2-minute approval assessment | 5-minute intake, clinician review typically within 5 hours and always within 24 |
| State coverage | Not published | 48 states |
| Tirzepatide | Not published | $149/mo |
| Patient reviews | 8,500 | 9,860 |
| eRxDoctor score | 9.9/10 | 7.5/10 |
Cost over a full course of treatment
Comparing entry prices across these two would be actively misleading, because they escalate differently. The figures underneath convert both offers into what you will have spent by month six and month twelve.
| Shed | SnagRx | |
|---|---|---|
| First month | Not published | $99 |
| Months 2 onward | Not published | $99/mo |
| 6-month total | Not computable | $594 |
| 12-month total | Not computable | $1,188 |
| Best published plan | No multi-month discount published | 12-month semaglutide plan at $69/mo ($828 a year) — $828/yr |
A like-for-like annual total is not available for Shed: Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. Treat any comparison that quotes one as an estimate someone else has made for you.
Pricing you can check, and pricing you cannot
With SnagRx the arithmetic is available in advance — Semaglutide $99/mo month-to-month, or $69/mo on the 12-month plan, on flat rate at every dose terms — so it can be compared against anything else on the market.
Shed runs the other way around — Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. There are defensible reasons for that; personalized plans genuinely do vary. The practical effect is still that you cannot comparison-shop it, and a completed intake is exactly the moment a quote lands with the most leverage.
Treat Shed's quote as the start of the comparison rather than the end of it, and check specifically what happens to the number at higher doses.
Inside the Shed program
Shed offers both name-brand and compounded GLP-1 weight loss medications with integrated coaching, a 2-minute approval assessment, and 10% off your first month. What it is really selling here is one of the few platforms that will write either a name-brand or a compounded GLP-1, with coaching bundled into the plan rather than sold beside it.
Getting started means 2-minute approval assessment, after which home delivery after clinician review. Pricing runs on a quoted only after intake basis, quote only, after intake.
Ongoing care is continuous coaching built into every treatment plan, and the medication list runs to name-brand FDA-approved GLP-1 and compounded GLP-1.
Shed pros
- Flexibility to choose medication type based on budget and needs
- Offers both FDA-approved name-brand GLP-1 and compounded options on one platform
- Continuous coaching is integrated into treatment, not just a prescription
- Fast 2-minute approval assessment
Shed cons
- Coaching-bundled model can cost more than bare-prescription platforms
- Standard pricing is not published, you receive a personalized quote after intake
- Name-brand options carry significantly higher costs than compounded alternatives
The reservation worth holding, particularly next to SnagRx: you cannot know what you will pay until you have finished the intake.
How SnagRx works
SnagRx offers compounded semaglutide from $69/month and tirzepatide from $119/month, with the rate locked flat at every dose, named US 503A pharmacies and next-day shipping. In this pairing, its distinguishing feature is the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly.
Intake is 5-minute intake, clinician review typically within 5 hours and always within 24. Fulfillment is free next-day UPS or FedEx in temperature-controlled packaging. The commercial terms are flat rate at every dose, published upfront.
Support: 1:1 nursing staff plus a secure patient portal for refills and dose changes. The medications on offer are compounded semaglutide and compounded tirzepatide.
SnagRx pros
- Price locked flat at every dose and at renewal — no re-pricing during titration
- Bottom-of-market pricing on the annual plan: $69/mo semaglutide, $119/mo tirzepatide
- States LegitScript certification, which patients can verify independently
- Names its four US 503A partner pharmacies and its clinician network (OpenLoop Health)
SnagRx cons
- The advertised $69 and $119 rates require the 12-month plan; month-to-month is $99 and $149
- Compounded medication only, no branded Ozempic, Wegovy, Mounjaro, or Zepbound
- No coaching or nutrition programming of any kind
Read next to Shed, the weak point: the advertised $69 and $119 rates require the 12-month plan — month-to-month is $99 and $149.
Who should choose Shed, and who should choose SnagRx
Choose Shed if:
- you want an FDA-approved finished medication rather than a compounded preparation
- you want continuous coaching built into every treatment plan rather than a prescription alone
- what it leads on is worth paying for in your case: one of the few platforms that will write either a name-brand or a compounded GLP-1, with coaching bundled into the plan rather than sold beside it
- the level of clinical contact suits you: continuous coaching built into every treatment plan
Choose SnagRx if:
- delivery works the way you want it to: free next-day UPS or FedEx in temperature-controlled packaging
- you want to start on their timeline: 5-minute intake, clinician review typically within 5 hours and always within 24
- the level of clinical contact suits you: 1:1 nursing staff plus a secure patient portal for refills and dose changes
- the feature you would actually use: the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly
The compromises on both sides
On price. Only SnagRx publishes a rate you can plan against (Semaglutide $99/mo month-to-month, or $69/mo on the 12-month plan). The other quotes after intake, which is a cost of a different kind: you cannot budget the year in advance.
On commitment. SnagRx rewards a longer commitment (12-month semaglutide plan at $69/mo ($828 a year)), which lowers the effective rate but ties up money before you know how you respond to the medication. Neither publishes financing options, so plan for the full amount each month.
On clinical contact. The support models differ — continuous coaching built into every treatment plan against 1:1 nursing staff plus a secure patient portal for refills and dose changes — and that difference is felt in week two, not week one.
On medication. Shed covers name-brand FDA-approved GLP-1 and compounded GLP-1; SnagRx covers compounded semaglutide and compounded tirzepatide. Only SnagRx publishes a tirzepatide route, which matters if semaglutide underdelivers.
What the trials and the FDA say
Neither Shed nor SnagRx manufactures the molecule it prescribes, and the clinical evidence behind GLP-1 treatment belongs to the drug rather than to any platform selling access to it.
The NIH position is that weight-management medication works alongside changes in eating and activity, not instead of them, per NIH, NIDDK.
The FDA publishes an ongoing record of semaglutide products marketed for diabetes and weight loss, and which of them it has actually approved, per FDA.
Read alongside the pricing above, that is the case for treating the medication decision as clinical and the provider decision as commercial. They are not the same choice.
Shed vs SnagRx: common questions
Which is cheaper to start, Shed or SnagRx?
Only SnagRx publishes a first-month figure (Semaglutide $99/mo month-to-month, or $69/mo on the 12-month plan). The other quotes after intake, so a starting-cost comparison is not available in advance.
How much does Shed cost?
Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. That is the honest answer, and it is the main practical drawback next to SnagRx, which publishes Semaglutide $99/mo month-to-month, or $69/mo on the 12-month plan upfront. If you go through the intake, ask for the month-two and maintenance-dose prices in writing before paying for the first month.
How fast can I start with Shed compared with SnagRx?
Shed advertises 2-minute approval assessment, with home delivery after clinician review. SnagRx advertises 5-minute intake, clinician review typically within 5 hours and always within 24, with free next-day UPS or FedEx in temperature-controlled packaging. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Do Shed or SnagRx take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
What happens if I stop taking the medication?
Both programs are month to month, which makes stopping easy and makes the consequence of stopping the thing to plan for: published extension data shows most of the lost weight returns within about a year. That is an argument for choosing on annual cost rather than entry price.
Are Shed and SnagRx legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. Shed operates on quoted only after intake with pricing quote only, after intake, SnagRx on flat rate at every dose, published upfront. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
Can I switch from Shed to SnagRx later?
You can, and people do — usually when an introductory price expires. Budget for a repeat intake and a short overlap in supply, and confirm what happens to any unused portion of a multi-month plan before you cancel it.
The verdict
Neither of these two publishes enough for a clean cost verdict, which is itself the finding. Shed leads on one of the few platforms that will write either a name-brand or a compounded GLP-1, with coaching bundled into the plan rather than sold beside it; SnagRx leads on the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly.
Before choosing either, get the maintenance-dose price in writing. Without it, any comparison — including this one — is working with half the information.
Whichever way you go, the medication is the same class of drug and the clinical questions belong to a clinician. What you are choosing here is a billing model and a support structure.
Keep comparing
- Shed vs WellmedrPublished price vs quote-only
- Shed vs Yucca HealthPublished price vs quote-only
- Directmeds vs SnagRxPublished price vs quote-only
- Measured vs SnagRxCoaching-supported vs medication-only
- Yucca Health vs WellorithmPublished price vs quote-only
- Yucca Health vs DirectmedsPublished price vs quote-only
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Shed or SnagRx, and does not sell treatment. Read our ranking methodology.